Adjunctive thalidomide therapy of childhood tuberculous meningitis: Possible anti-inflammatory role

Journal of Child Neurology

Volumn 15, Issue 8, 2000, Pages 497-503

  Schoeman, Johan F ^a   Springer, Priscilla ^a   Ravenscroft, Alice ^a   Donald, Peter R ^a   Bekker, Linda Gail ^b   van Rensburg, Anita Janse ^a   Hanekom, Willem A ^c   Haslett, Patrick A J ^c   Kaplan, Gilla ^c  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; THALIDOMIDE; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; IMMUNOMODULATION; INFANT; INTRACRANIAL HYPERTENSION; PRIORITY JOURNAL; RASH; TREATMENT OUTCOME; TUBERCULOUS MENINGITIS;

ADJUVANTS, IMMUNOLOGIC; ANTITUBERCULAR AGENTS; BIOLOGICAL MARKERS; BRAIN; CHILD; CHILD, PRESCHOOL; CLINICAL PROTOCOLS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; INFLAMMATION; INTRACRANIAL PRESSURE; MALE; MYCOBACTERIUM TUBERCULOSIS; PILOT PROJECTS; THALIDOMIDE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUBERCULOSIS, MENINGEAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033840044     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380001500801     Document Type: Article

References (17)

1. Notifiable medical conditions
2. Pediatric meningitis in the Western Cape Province of South Africa
3. Tuberculous meningitis in children in the Western Cape Epidemiology and outcome
4. The many facets of neurotuberculosis: An epitome of neuropathology
5. Tuberculous hydrocephalus: Comparison of different treatments with regard to intracranial pressure, ventricular size and clinical outcome
6. Serial CT scanning in childhood tuberculous meningitis: Prognostic features in 198 cases
7. Paradoxical enlargement or development of intracranial tuberculomas during therapy: Case report and review
8. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis
9. Concentrations of interferon γ, tumor necrosis factor α, and interleukin 1β in the cerebrospinal fluid of children treated for tuberculous meningitis
10. Thalidomide exerts its inhibitory action on tumor necrosis factor-α by enhancing mRNA degradation
11. A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death
12. Streptomycin treatment of tuberculous meningitis
13. Adverse reactions to thalidomide in patients infected with human immunodeficiency virus
14. Pathophysiology and treatment of focal ischemia. Part 1: Pathophysiology
15. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice
16. Endotoxin concentrations in cerebrospinal fluid correlate with clinical severity and neurological outcome of Haemophilus influenzae type b meningitis
17. Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset